Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
The HemOnc Pulse
Comparing Side Effects and Quality of Life Impact of Novel Therapy in DLBCL
Exploration of the side effects and accessibility of a novel therapy compared to CAR-T therapy. Focus on lower-grade CRS, step-up dosing strategy for risk management, and enhanced accessibility in community sites for improved quality of life.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
